Leyden Laboratories
Develops broadly protective antibody-based nasal sprays to prevent infection by influenza and other respiratory viruses
€40MSeries B
Role not disclosedLoading investors…
Loading investors…
Activity from announced rounds
Develops broadly protective antibody-based nasal sprays to prevent infection by influenza and other respiratory viruses
Develops advanced 3D scanning probe metrology and inspection systems for semiconductor manufacturing
Develops AI acceleration hardware for edge computing and data center applications
Pitching Invest-NL? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room